BPG is committed to discovery and dissemination of knowledge
Citation
Pakvisal N, Goldberg RM, Sathitruangsak C, Silaphong W, Faengmon S, Teeyapun N, Teerapakpinyo C, Tanasanvimon S. Overall survival with frontline vs subsequent anti-epidermal growth factor receptor therapies in unresectable, RAS/BRAF wild-type, left-sided metastatic colorectal cancer. World J Clin Oncol 2025; 16(3): 102076 [PMID: 40130051 DOI: 10.5306/wjco.v16.i3.102076]
Please LOGIN to submit a new comment.